Expert disputes

Where experts disagree.

The arguments most peptide sites pretend don't exist. Real disputes between named experts — both sides, the bottom line, and what to do with the disagreement.

Compound choice

Compound choice · 3

Retatrutide vs Tirzepatide for lifters

Position A

Retatrutide is superior — glucagon receptor preserves lean mass, 24% vs 21% weight loss, 40% new mitochondria. Triple-action beats dual.

— Dr. Bachmeyer, Dr. Jones DC, Jay Campbell

Position B

Tirzepatide is preferred for GLP-1 receptor-specific benefits (brain, immune, joint). Reta has 'very little actual GLP-1 component' for those targets.

— Dr. Tyna Moore

Bottom line

Reta if you lift and want lean mass preservation. Tirz if you want broader GLP-1 benefits and don't care about the glucagon edge. Never stack them — Bachmeyer warns of 'metabolic whiplash' and 60% regain in 6 months.

Sermorelin vs CJC-1295 for sleep/GH

Position A

Sermorelin is budget-friendly, gentle, great for sleep. Clinically appropriate for most people.

— JD Denham, XSculpt, Dr. Froese

Position B

Sermorelin was groundbreaking in the '90s. CJC no-DAC does it better now — better GH pulse, better results. Sermorelin is obsolete.

— Hunter Williams

Bottom line

CJC no-DAC + Ipamorelin is the current consensus for performance. Sermorelin is fine if cost matters. For serious goals, go CJC/Ipa.

MK-677 — yes or no for 35+

Position A

MK-677 ~25mg nightly boosts GH for muscle/sleep. Stacks with IGF-1 LR3 for elderly muscle. 35+ framework but viable for serious lifters.

— JD Denham

Position B

F-tier — raises insulin resistance. A1C hit pre-diabetic range on personal trial. Water retention debilitating. Banned from compounding 2023.

— Dr. Alex Tatem, Dr. Jones DC

Bottom line

Hard pass. Two doctors, one with personal data, say it fights fat-loss goals directly. If you're managing insulin sensitivity, MK-677 works against you.

Dosing & timing

Dosing & timing · 4

HGH timing — morning or night

Position A

Morning only — preserves natural nocturnal GH pulse. Taking at night suppresses endogenous production.

— Jay Campbell, JD Denham

Position B

Night injection aligns with body's natural 8x/day repair pulse. Morning HGH is 'mostly wasted.'

— Anthony Castore (EliteFTS)

Bottom line

Use secretagogues (CJC/Ipa) at night — physiological and consensus. If running actual exogenous HGH, morning is the safer call to preserve your endogenous pulse.

BPC-157 — oral, SubQ, or IM

Position A

Oral 1,000+ mcg works for injuries past the gut. Reaching systemic targets requires higher oral dose.

— Jay Campbell

Position B

Oral BPC from Amazon is a completely different product than pharmaceutical injectable. Same name, different risk profile. Injectable only for real results.

— Dr. Jones DC, Dr. Froese, Nick Trigili

Bottom line

Gut healing: oral is fine at high dose. Joint/tendon/systemic: injectable SubQ near the site. Don't buy BPC oral from Amazon — compounding pharmacy only.

Cycling on/off vs continuous use

Position A

Cycle everything — 8–12 weeks on, 4–8 weeks off minimum. Receptor desensitization and antibody buildup make continuous use self-defeating.

— Jay Campbell, Nick Trigili

Position B

BPC-157 is the 'forever peptide' — low continuous daily dose outperforms cycled blast protocols long-term. Consistency beats intensity.

— Dr. Bachmeyer

Bottom line

Compound-specific. BPC-157 at low dose: continuous OK. MOTS-c, longevity peptides: cycle. GLP-1s and GH secretagogues: definitely cycle.

IGF-1 LR3 — timing relative to carbs

Position A

Inject post-workout, eat carbs within 20–30 min. The 20–30 hour half-life makes timing window critical.

— JD Denham, Anthony Castore (EliteFTS)

Position B

IGF-1 LR3 doesn't cause cancer. The cancer/IGF-1 link is from metabolic dysfunction, not the peptide. Timing is less discussed.

— Dr. Bachmeyer

Bottom line

If you ever run IGF-1 LR3: post-workout + carbs within 30 min is the consensus protocol. Dose to lean body mass, not total body weight.

Stacking

Stacking · 1

Reta + Tirz combined — viable or dangerous

Position A

Receptor saturation causes 'metabolic whiplash.' Mitochondrial damage byproducts +68%. Less ATP than either solo. 60% weight regain in 6 months.

— Dr. Bachmeyer

Position B

The 'dangerous combo' warning is clickbait with zero supporting studies.

— Hunter Williams

Bottom line

Skip the combo. Bachmeyer's mechanism is plausible even without published RCT. If you want what each does, alternate cycles — don't co-administer.

Lifestyle & diet

Lifestyle & diet · 1

Carnivore + IF vs balanced macros for fat loss

Position A

Carnivore + IF is already producing the results most people seek from GLP-1s. Amplifies peptide protocols.

— JD Denham

Position B

Retatrutide requires 40–55% carbs (100–200g/day). Glucagon receptor needs carbs to burn fat cleanly. Keto cuts Reta effectiveness ~40%.

— Dr. Bachmeyer

Bottom line

If you're on Reta: Bachmeyer wins — glucagon receptor activation requires glucose. Carnivore kills your Reta ROI. Off Reta: lifestyle preference.

Biomarkers

Biomarkers · 1

LDL on TRT — concern or not

Position A

Only particle size and inflammation matter. Cholesterol score is a bad heart marker. Standard lipid panels are a distraction.

— Jay Campbell, Hunter Williams

Position B

LDL causes plaque even in metabolically healthy lean mass hyperresponders — the LMHR group grew 18mm plaque/year. 'We have never reached a point where low is bad.'

— Dr. Layne Norton, Talking With Docs

Bottom line

Get an ApoB and calcium score, not just standard lipid panel. Norton's data is hard to dismiss. Don't assume TRT + high LDL is fine just because you feel good.

How to read these.

Two named experts arguing isn't a tie. It's a flag that the evidence is incomplete enough that thoughtful practitioners can land on opposite sides. The bottom line column is our best read for the typical user — not a verdict.

Open questionsHow to startAsk the AI